Predictors of subclinical atheromatosis progression over 2 years in patients with different stages of CKD

Clinical Journal of the American Society of Nephrology

Volumn 11, Issue 2, 2016, Pages 287-296

  Gracia, Marta ^a   Betriu, Àngels ^a   Martínez Alonso, Montserrat ^a   Arroyo, David ^b   Abajo, María ^a   Fernández, Elvira ^a   Valdivielso, José M ^a  

^a UNIVERSITY OF LLEIDA   (Spain)

^b HOSPITAL ARNAU DE VILANOVA   (Spain)

Author keywords

Atherosclerosis; Blood pressure; Cardiovascular disease; Carotid intima media thickness; Chronic kidney disease; Follow up studies; Humans; Renal insufficiency, chronic; Smoking; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; FERRITIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE BINDING AGENT; URIC ACID;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROMATOSIS; ATHEROSCLEROTIC PLAQUE; BODY MASS; CHRONIC KIDNEY DISEASE; DIABETES MELLITUS; DISEASE COURSE; DYSLIPIDEMIA; ECHOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PREVALENCE; PROSPECTIVE STUDY; SMOKING; AGED; ASYMPTOMATIC DISEASE; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMMON CAROTID ARTERY; COMORBIDITY; COMPARATIVE STUDY; DIAGNOSTIC IMAGING; FEMORAL ARTERY; LIFESTYLE; LONGITUDINAL STUDY; MIDDLE AGED; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTOR; SEVERITY OF ILLNESS INDEX; SPAIN; STATISTICAL MODEL; TIME FACTOR;

ADULT; AGED; ASYMPTOMATIC DISEASES; ATHEROSCLEROSIS; CAROTID ARTERY DISEASES; CAROTID ARTERY, COMMON; CAROTID INTIMA-MEDIA THICKNESS; CHI-SQUARE DISTRIBUTION; COMORBIDITY; DISEASE PROGRESSION; FEMALE; FEMORAL ARTERY; HUMANS; LIFE STYLE; LOGISTIC MODELS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PLAQUE, ATHEROSCLEROTIC; PREVALENCE; PROSPECTIVE STUDIES; RENAL INSUFFICIENCY, CHRONIC; RISK ASSESSMENT; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SPAIN; TIME FACTORS;

EID: 84957098954     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01240215     Document Type: Article

References (43)

1. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY: Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 351: 1296-1305, 2004.
2. ChangA, KramerH: Should eGFR and albuminuria be added to the Framinghamrisk score? Chronic kidney disease and cardiovascular disease risk prediction. Nephron Clin Pract 119: c171-c177, 2011.
3. Coll B, Betriu A, Martínez-Alonso M, Borràs M, Craver L, Amoedo ML, Marco MP, Sarró F, Junyent M, Valdivielso JM, Fernández E: Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: Usefulness of noninvasive tests in cardiovascular assessment. Nephrol Dial Transplant 25: 3017-3025, 2010.
4. Lamprea-Montealegre JA, Astor BC, McClelland RL, de Boer IH, Burke GL, Sibley CT, O'Leary D, Sharrett AR, Szklo M: CKD, plasma lipids, and common carotid intima-media thickness: Results from the multi-ethnic study of atherosclerosis. Clin J Am Soc Nephrol 7: 1777-1785, 2012.
5. Weiner DE, Tighiouart H, Griffith JL, Elsayed E, Levey AS, Salem DN, Sarnak MJ: Kidney disease, Framingham risk scores, and cardiac and mortality outcomes. Am J Med 120: 552.e1-552.e8,2007.
6. Polak JF, Pencina MJ, Pencina KM, O'Donnell CJ, Wolf PA, D'Agostino RB Sr.: Carotid-wall intima-media thickness and cardiovascular events. N Engl J Med 365: 213-221, 2011.
7. Silverman MG, Harkness JR, Blankstein R, Budoff MJ, Agatston AS, Carr JJ, Lima JA, Blumenthal RS, Nasir K, Blaha MJ: Baseline subclinical atherosclerosis burden and distribution are associated with frequency and mode of future coronary revascularization: Multi-ethnic study of atherosclerosis. JACC Cardiovasc Imaging 7: 476-486, 2014.
8. Katakami N, Kaneto H, Shimomura I: Carotid ultrasonography: A potent tool for better clinical practice in diagnosis of atherosclerosis in diabetic patients. J Diabetes Investig 5: 3-13, 2014.
9. Inaba Y, Chen JA, Bergmann SR: Carotid plaque, compared with carotid intima-media thickness, more accurately predicts coronary artery disease events: A meta-analysis. Atherosclerosis 220:128-133, 2012.
10. Benedetto FA, Tripepi G, Mallamaci F, Zoccali C: Rate of atherosclerotic plaque formation predicts cardiovascular events in ESRD. J Am Soc Nephrol 19: 757-763, 2008.
11. KimJK, Song YR, KimMG, KimHJ, KimSG: Clinical significance of subclinical carotid atherosclerosis and its relationship with echocardiographic parameters in non-diabetic chronic kidney disease patients. BMC Cardiovasc Disord 13: 96, 2013.
12. Nakano T, Ninomiya T, Sumiyoshi S, Fujii H, Doi Y, Hirakata H, Tsuruya K, Iida M, Kiyohara Y, Sueishi K: Association of kidney function with coronary atherosclerosis and calcification in autopsy samples from Japanese elders: The Hisayama study. Am J Kidney Dis 55: 21-30, 2010.
13. Betriu A, Martinez-AlonsoM, Arcidiacono MV, Cannata-Andia J, Pascual J, Valdivielso JM, Fernández E; Investigators from the NEFRONA Study: Prevalence of subclinical atheromatosis and associated risk factors in chronic kidney disease: The NEFRONA study. Nephrol Dial Transplant 29: 1415-1422, 2014.
14. ChoncholM,Whittle J,Desbien A,OrnerMB, Petersen LA, Kressin NR: Chronic kidney disease is associated with angiographic coronary artery disease. Am J Nephrol 28: 354-360, 2008.
15. Herzog CA: Cardiac arrest in dialysis patients: Approaches to alter an abysmal outcome. Kidney Int Suppl 63: S197-S200,2003.
16. Arroyo D, Betriu A, Martinez-Alonso M, Vidal T, Valdivielso JM, Fernández E; investigators from the NEFRONA study: Observational multicenter study to evaluate the prevalence and prognosis of subclinical atheromatosis in a Spanish chronic kidney disease cohort: Baseline data from the NEFRONA study. BMC Nephrol 15: 168, 2014.
17. Leoncini G, Viazzi F, Parodi D, Ratto E, Vettoretti S, Vaccaro V, RaveraM,DeferrariG, Pontremoli R:Mild renal dysfunction and cardiovascular risk in hypertensive patients. J Am Soc Nephrol 15[Suppl 1]: S88-S90, 2004.
18. Kokubo Y: Carotid atherosclerosis in kidney disease. Contrib Nephrol 179: 35-41, 2013.
19. Olechnowicz-Tietz S,Gluba A, Paradowska A, Banach M, Rysz J: The risk of atherosclerosis in patients with chronic kidney disease. Int Urol Nephrol 45: 1605-1612, 2013.
20. Leskinen Y, Lehtimäki T, Loimaala A, Lautamatti V, Kallio T, Huhtala H, Salenius JP, Saha H: Carotid atherosclerosis in chronic renal failure-the central role of increased plaque burden. Atherosclerosis 171: 295-302, 2003.
21. Arbel Y, Halkin A, Finkelstein A, Revivo M, Berliner S, Herz I, Keren G, Banai S: Impact of estimated glomerular filtration rate on vascular disease extent and adverse cardiovascular events in patients without chronic kidney disease. Can J Cardiol 29: 1374-1381, 2013.
22. Rigatto C, Levin A, House AA, Barrett B, Carlisle E, Fine A: Atheroma progression in chronic kidney disease. Clin J Am Soc Nephrol 4: 291-298, 2009.
23. Desbien AM, ChoncholM, Gnahn H, Sander D: Kidney function and progression of carotid intima-media thickness in a community study. Am J Kidney Dis 51: 584-593, 2008.
24. Junyent M, Martínez M, Borràs M, Coll B, Valdivielso JM, Vidal T, Sarró F, Roig J, Craver L, Fernández E: Predicting cardiovascular disease morbidity and mortality in chronic kidney disease in Spain. The rationale and design of NEFRONA: A prospective, multicenter, observational cohort study. BMC Nephrol 11: 14,2010.
25. Junyent M, Martínez M, Borrás M, Bertriu A, Coll B, Craver L, Marco MP, Sarró F, Valdivielso JM, Fernández E: Usefulness of imaging techniques and novel biomarkers in the prediction of cardiovascular risk in patients with chronic kidney disease in Spain: The NEFRONA project. Nefrologia 30: 119-126, 2010.
26. de La Piedra C, Fernández E, González Casaus ML, González Parra E: Different biological functions in PTH molecules. What are we measuring? Nefrologia 28: 123-128, 2008.
27. Coll B, Betriu A, Martínez-Alonso M, Amoedo ML, Arcidiacono MV, Borras M, Valdivielso JM, Fernández E: Large artery calcification on dialysis patients is located in the intima and related to atherosclerosis. Clin J Am Soc Nephrol 6: 303-310, 2011.
28. Stein JH, Korcarz CE, Hurst RT, Lonn E, Kendall CB, Mohler ER, Najjar SS, Rembold CM, Post WS; American Society of Echocardiography Carotid Intima-Media Thickness Task Force; Endorsed by the Society for Vascular Medicine: Use of carotid ultrasound to identify subclinical vascular disease and evaluate cardiovascular disease risk: A consensus statement from the American Society of Echocardiography Carotid Intima-Media Thickness Task Force. J Am Soc Echocardiogr 21: 93-111, 2008.
29. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Desvarieux M, Ebrahim S, Fatar M, Hernandez R, Kownator S, Prati P, Rundek T, Taylor A, Bornstein N, Csiba L, Vicaut E, Woo KS, Zannad F; Advisory Board of the 3rdWatching the Risk Symposium 2004, 13th European Stroke Conference: Mannheim intima-media thickness consensus. Cerebrovasc Dis 18: 346-349, 2004.
30. Tattersall MC, Gassett A, Korcarz CE, Gepner AD, Kaufman JD, Liu KJ, Astor BC, Sheppard L, Kronmal RA, Stein JH: Predictors of carotid thickness and plaque progression during a decade: The Multi-Ethnic Study of Atherosclerosis. Stroke 45: 3257-3262,2014.
31. van der Meer IM, Iglesias del Sol A, Hak AE, BotsML, Hofman A, Witteman JCM: Risk factors for progression of atherosclerosis measured at multiple sites in the arterial tree: The Rotterdam Study. Stroke 34: 2374-2379, 2003.
32. Herder M, Johnsen SH, Arntzen KA, Mathiesen EB: Risk factors for progression of carotid intima-media thickness and total plaque area: A 13-year follow-up study: The Tromsø Study. Stroke 43: 1818-1823, 2012.
33. Valdivielso JM, Coll B, Fernandez E: Vitamin D and the vasculature: Can we teach an old drug new tricks? Expert Opin Ther Targets 13: 29-38, 2009.
34. Bozic M, Panizo S, Sevilla MA, Riera M, Soler MJ, Pascual J, Lopez I, Freixenet M, Fernandez E, Valdivielso JM: High phosphate diet increases arterial blood pressure via a parathyroid hormone mediated increase of renin. J Hypertens 32: 1822-1832, 2014.
35. EllamTJ, Chico TJA: Phosphate: The new cholesterol? The role of the phosphate axis in non-uremic vascular disease. Atherosclerosis 220: 310-318, 2012.
36. Martín M, Valls J, Betriu A, Fernández E, Valdivielso JM: Association of serum phosphorus with subclinical atherosclerosis in chronic kidney disease. Sex makes a difference. Atherosclerosis 241: 264-270, 2015.
37. Bozic M, Álvarez Á, de Pablo C, Sanchez-Ni~no MD, Ortiz A, Dolcet X, Encinas M, Fernandez E, Valdivielso JM: Impaired Vitamin D Signaling in Endothelial Cell Leads to an Enhanced Leukocyte-Endothelium Interplay: Implications for Atherosclerosis Development. PLoS One 10: e0136863, 2015.
38. Suki WN; Dialysis Clinical Outcomes Revisited Investigators: Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients: Results of a randomized clinical trial. J Ren Nutr 18: 91-98, 2008.
39. Xia X, He F, Wu X, Peng F, Huang F, Yu X: Relationship between serum uric acid and all-cause and cardiovascular mortality in patients treated with peritoneal dialysis. Am J Kidney Dis 64:257-264, 2014.
40. Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rincón A, Arroyo D, Lu~no J: Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5: 1388-1393, 2010.
41. Yadav AK, Banerjee D, Lal A, Jha V: Vitamin D deficiency, CD4+CD28null cells and accelerated atherosclerosis in chronic kidney disease. Nephrology (Carlton) 17: 575-581, 2012.
42. Szeto FL, Reardon CA, YoonD,Wang Y,Wong KE, Chen Y, Kong J, Liu SQ, Thadhani R, GetzGS, Li YC: VitaminDreceptor signaling inhibits atherosclerosis in mice. Mol Endocrinol 26: 1091-1101,2012.
43. Valcheva P, Cardus A, Panizo S, Parisi E, Bozic M, Lopez Novoa JM, Dusso A, Fernández E, Valdivielso JM: Lack of vitamin D receptor causes stress-induced premature senescence in vascular smooth muscle cells through enhanced local angiotensin-II signals. Atherosclerosis 235: 247-255, 2014.